Indefinite Delivery Contract SPE2DB24D6038

The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00. The IDC's period of performance extends through December 31, 2025 and serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Firm fixed price task orders issued under this IDC enable Amerisourcebergen to provide a comprehensive range of medications and healthcare materials, including specialty, brand name, generic, and over-the-counter pharmaceuticals, as well as medical materials such as syringes, vials, test kits, and other critical care supplies, to military treatment programs and medical facilities worldwide. This IDC was awarded solely to Amerisourcebergen Drug Corp as a single award contract and does not fall under any overarching contract vehicles. No set-aside designations have typically been used for these types of DLA contracts.